"Endless waits alone in crowds, cancer patients at risk in Cagliari": the case in the Regional Council
Fratelli d'Italia questions: "Patients are waiting hours longer than clinically justifiable for transfusion therapy."Per restare aggiornato entra nel nostro canale Whatsapp
"Waits for transfusion therapies are prolonged for hours beyond clinically justifiable times." And again: "Those who wait, and who are sick, must do so in crowded waiting rooms lacking adequate protective measures, where they are exposed to a high risk of contagion." Furthermore, "oncology and transfusion therapies are performed on the sixth floor of the facility, while patients' companions are required to wait on the ground floor, depriving patients of necessary physical and psychological support (ambulation, management of side effects, emotional distress)."
The list of "serious organizational and healthcare dysfunctions" attributed to the Cagliari Oncology Center managed by Arnas Brotzu is long and detailed, and is confidential in a question presented by the Brothers of Italy group in the Regional Council, with Cristina Usai as the first signatory.
Serious critical issues are described at a center that "represents a regional and national reference health facility for the care of oncology and hemato-oncology patients, many of whom are immunosuppressed, elderly, or suffer from disabling diseases."
Critical issues in the management of peripherally inserted central catheter (PICC) devices, behaviors inappropriate for the healthcare setting, and a general climate of patient humiliation have also been reported.
Usai and his opposition colleagues ask whether the Health Councilor, and therefore President Alessandra Todde, who is serving as interim president, "intends to order an urgent inspection, including through the relevant regional services, to verify compliance with current regulations, clinical and organizational protocols, and patient rights." They also ask whether "there are official protocols and company documents governing the management of priorities and waiting lists for transfusion and cancer treatments, and if so, how their uniform and verifiable application is guaranteed."
(Unioneonline/E.Fr.)
